Whiteoak Capital Pharma And Healthcare Fund Overview
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 21-02-2025
NAV ₹12.15(R) -1.53% ₹12.38(D) -1.53%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 19.6% -% -% -% -%
Direct 21.69% -% -% -% -%
Nifty Pharma TRI 8.49% 16.98% 20.4% 13.51% 6.47%
SIP (XIRR) Regular 11.97% -% -% -% -%
Direct 13.99% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Top Pharma Fund
Fund Name Rank Rating
Sbi Healthcare Opportunities Fund -
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Tata India Pharma & Healthcare Fund -
Dsp Healthcare Fund -
Uti Healthcare Fund -
Nippon India Pharma Fund -
Mirae Asset Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -

NAV Date: 21-02-2025

Scheme Name NAV Rupee Change Percent Change
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 12.15
-0.1900
-1.5300%
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth 12.38
-0.1900
-1.5300%

Review Date: 21-02-2025

A review of the different performance parameters of the fund is as follows:
  1. Returns: It reflects the surge in the investment's value throughout the investment period, communicated as a percentage or a specific monetary sum. Our analysis encompassed four return parameters of this fund. We have organized the return parameters into three performance groups for evaluation: the top 25%, parameters that rank below the top 25% but above average, and parameters that are below average. Below, you'll find a breakdown of how each parameter has performed.
    1. Top 25%: Three return parameters of the Whiteoak Capital Pharma And Healthcare Fund are in the top 25% in the category, as shown below:
      • 3M Return %
      • 6M Return %
      • 1Y Return %
    2. Above Average Below the Top 25%: One return parameter of the Whiteoak Capital Pharma And Healthcare Fund is above average but below the top 25% in the category, as shown below:
      • 1M Return %
    3. Below Average: Whiteoak Capital Pharma And Healthcare Fund has no return parameters that are below average in the category.
  2. Risk: The threat of not realizing projected profits or even facing financial loss due to different issues is known as risk. For Whiteoak Capital Pharma And Healthcare Fund, we have analyzed zero risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: Whiteoak Capital Pharma And Healthcare Fund does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: Whiteoak Capital Pharma And Healthcare Fund does not have any risk parameters in the below average but above the lowest 25% of the category.
    3. Above Average: Whiteoak Capital Pharma And Healthcare Fund does not have any risk parameters above average; which is a good sign.
  3. Risk Adjusted Performance Parameters: Risk-adjusted performance parameters in mutual funds are parameters that assess the return on investments based on the risks involved. These parameters provide a platform for investors to compare various investments, by considering both profits and the risks involved. For Whiteoak Capital Pharma And Healthcare Fund, we have evaluated zero risk-adjusted performance parameters.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
    3. Below Average Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -6.72 -6.64
-6.97
-9.04 | -5.72 6 | 13 Good
3M Return % -5.02 -6.02
-6.79
-9.68 | -4.84 2 | 13 Very Good
6M Return % -0.25 -9.49
-6.24
-17.69 | -0.25 1 | 13 Very Good
1Y Return % 19.60 8.49
11.55
1.74 | 21.28 2 | 13 Very Good
1Y SIP Return % 11.97
1.08
-11.88 | 13.28 2 | 13 Very Good
Return data last Updated On : Feb. 21, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Jan. 31, 2025
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -6.60 -6.64 -6.87 -8.93 | -5.64 6 | 13
3M Return % -4.61 -6.02 -6.48 -9.30 | -4.55 2 | 13
6M Return % 0.61 -9.49 -5.62 -16.99 | 0.61 1 | 13
1Y Return % 21.69 8.49 13.01 3.43 | 22.79 2 | 13
1Y SIP Return % 13.99 2.46 -10.32 | 14.73 2 | 13
Return data last Updated On : Feb. 21, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Jan. 31, 2025
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D -1.53 ₹ 9,847.00 -1.53 ₹ 9,847.00
1W -0.86 ₹ 9,914.00 -0.83 ₹ 9,917.00
1M -6.72 ₹ 9,328.00 -6.60 ₹ 9,340.00
3M -5.02 ₹ 9,498.00 -4.61 ₹ 9,539.00
6M -0.25 ₹ 9,975.00 0.61 ₹ 10,061.00
1Y 19.60 ₹ 11,960.00 21.69 ₹ 12,169.00
3Y ₹ ₹
5Y ₹ ₹
7Y ₹ ₹
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 11.97 ₹ 12,768.70 13.99 ₹ 12,895.57
3Y ₹ 36000 ₹ ₹
5Y ₹ 60000 ₹ ₹
7Y ₹ 84000 ₹ ₹
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Whiteoak Capital Pharma And Healthcare Fund NAV Regular Growth Whiteoak Capital Pharma And Healthcare Fund NAV Direct Growth
21-02-2025 12.151 12.376
20-02-2025 12.34 12.568
19-02-2025 12.269 12.496
18-02-2025 12.28 12.506
17-02-2025 12.322 12.548
14-02-2025 12.256 12.48
13-02-2025 12.592 12.821
12-02-2025 12.54 12.767
11-02-2025 12.588 12.815
10-02-2025 12.981 13.215
07-02-2025 13.301 13.539
06-02-2025 13.303 13.541
05-02-2025 13.303 13.54
04-02-2025 13.121 13.354
03-02-2025 12.897 13.125
31-01-2025 12.867 13.093
30-01-2025 12.79 13.014
29-01-2025 12.642 12.863
28-01-2025 12.289 12.503
27-01-2025 12.556 12.774
24-01-2025 12.921 13.143
23-01-2025 13.184 13.411
22-01-2025 12.981 13.203
21-01-2025 13.027 13.25

Fund Launch Date: 06/Feb/2024
Fund Category: Pharma Fund
Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Description: An open ended equity scheme investing in Pharma and Healthcare sector
Fund Benchmark: BSE Healthcare Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.